Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Allergan Plc (AGN US)
Watchlist
90
Analysis
Health Care
•
United States
Allergan plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Allergan offers its pharmaceutical drugs around the world.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Bausch Health Companies
•
29 Nov 2015 18:10
Valeant & Philidor Bezzle: Clarity Will Take Awhile
It has been two weeks since I published The Valeant Bezzle Saga Continues: Confidence Game? and four weeks since VALEANT & Philidor Bezzle: On...
Travis Lundy
Follow
1.1k Views
Share
bullish
•
Thematic (Sector/Industry)
•
12 Nov 2015 01:34
Healthcare Observer: As Long-Term Patent Exposure Ebbs, Innovation in Big Pharma Pipelines Support
Pipeline innovation outpacing patent losses represents a core element of the wide moat ratings for most of the Big Pharma firms. Slowing patent...
Morningstar, Inc.
394 Views
Share
bearish
•
Thematic (Sector/Industry)
•
11 Oct 2015 15:13
HILLARY! Scourge of Wall, Savior of Main - Preventer of Market Crashes, and Economic Crises
On October 8th, Hillary Clinton offered an Op-Ed on Bloomberg Views (available on the website here) which was a shorter version of...
Travis Lundy
Follow
339 Views
Share
bearish
•
Cross Asset Strategy
•
08 Oct 2015 18:02
Many (un)happy returns in EM; governance and the vicious circle
This report examines the underlying governance factors that have driven EM underperformance over the last five years.Brazil, Russia, Malaysia and...
John-Paul Smith
323 Views
Share
bullish
•
Thematic (Sector/Industry)
•
07 Oct 2015 03:15
Morningstar Healthcare Observer: Biotech Industry Undervalued
The median price/fair value in our biotech universe is 0.87, and in late September valuations fell to their cheapest levels since 2011. While this...
Morningstar, Inc.
375 Views
Share
First
Previous
13
14
15
16
17
18
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x